T1	Participants 164 227	patients with chronic heart failure after myocardial infarction
T2	Participants 364 395	patients with heart failure (HF
T3	Participants 560 619	patients with class II to IV HF and ejection fraction <35%.
T4	Participants 773 888	330 patients intended for enrollment, 23 were randomized (MARVEL-1) before stopping the study for financial reasons